Literature DB >> 23788427

TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling.

Laurent Fattet1, Anne-Sophie Ay, Benjamin Bonneau, Laurent Jallades, Ivan Mikaelian, Isabelle Treilleux, Germain Gillet, Cédric Hesling, Ruth Rimokh.   

Abstract

TIF1γ, a new regulator of TGFβ signaling, inhibits the Smad4-mediated TGFβ response by interaction with Smad2/3 or ubiquitylation of Smad4. We have shown that TIF1γ participates in TGFβ signaling as a negative regulator of Smad4 during the TGFβ-induced epithelial-to-mesenchymal transition (EMT) in mammary epithelial cells, and during terminal differentiation of mammary alveolar epithelial cells and lactation. We demonstrate here that TIF1γ is sumoylated and interacts with Ubc9, the only known SUMO-conjugating enzyme. Four functional sumoylation sites lie within the middle domain of TIF1γ, the Smad interaction domain. We show that a sumoylation-defective TIF1γ mutant significantly reduces TIF1γ inhibition of Smad complexes and that of the Smad-mediated TGFβ transcriptional response. Moreover, chromatin immunoprecipitation experiments indicate that TIF1γ sumoylation is required to limit Smad4 binding on the PAI-1 TGFβ target gene promoter. Ectopic expression of TIF1γ in mammary epithelial cells inhibits TGFβ-induced EMT, an effect relieved by expression of non-sumoylated TIF1γ. Taken together, our results identify a new TGFβ regulatory layer, whereby sumoylation strengthens the TIF1γ repressive action on canonical TGFβ signaling.

Entities:  

Keywords:  Smad; Sumoylation; TGFbeta; TIF1gamma; TRIM33

Mesh:

Substances:

Year:  2013        PMID: 23788427     DOI: 10.1242/jcs.126748

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 2.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

3.  Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.

Authors:  L Wang; H Yang; Z Lei; J Zhao; Y Chen; P Chen; C Li; Y Zeng; Z Liu; X Liu; H-T Zhang
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 4.  Posttranslational Regulation of Smads.

Authors:  Pinglong Xu; Xia Lin; Xin-Hua Feng
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

5.  Desuppression of TGF-β signaling via nuclear c-Abl-mediated phosphorylation of TIF1γ/TRIM33 at Tyr-524, -610, and -1048.

Authors:  Ryuzaburo Yuki; Takashi Tatewaki; Noritaka Yamaguchi; Kazumasa Aoyama; Takuya Honda; Sho Kubota; Mariko Morii; Ichiro Manabe; Takahisa Kuga; Takeshi Tomonaga; Naoto Yamaguchi
Journal:  Oncogene       Date:  2018-09-03       Impact factor: 9.867

6.  Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Authors:  Xiaopeng Lan; Guoliang Lu; Chuanwei Yuan; Shaowei Mao; Wei Jiang; Yougen Chen; Xunbo Jin; Qinghua Xia
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-24       Impact factor: 4.553

7.  PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.

Authors:  Ayan Chanda; Yoshiho Ikeuchi; Kunal Karve; Anusi Sarkar; Amrita Singh Chandhoke; Lili Deng; Azad Bonni; Shirin Bonni
Journal:  Cell Death Differ       Date:  2020-08-07       Impact factor: 15.828

8.  Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.

Authors:  Sina V Barysch; Nicolas Stankovic-Valentin; Tim Miedema; Samir Karaca; Judith Doppel; Thiziri Nait Achour; Aarushi Vasudeva; Lucie Wolf; Carsten Sticht; Henning Urlaub; Frauke Melchior
Journal:  EMBO Rep       Date:  2021-01-22       Impact factor: 8.807

9.  TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.

Authors:  Loay Kassem; Mathieu Deygas; Laurent Fattet; Jonathan Lopez; Thibaut Goulvent; Emilie Lavergne; Sylvie Chabaud; Nicolas Carrabin; Nicolas Chopin; Thomas Bachelot; Germain Gillet; Isabelle Treilleux; Ruth Rimokh
Journal:  BMC Cancer       Date:  2015-06-04       Impact factor: 4.430

10.  Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.

Authors:  Hanbo Yang; Qinglin Peng; Liguo Yin; Shanshan Li; Jingli Shi; Yamei Zhang; Xin Lu; Xiaoming Shu; Sigong Zhang; Guochun Wang
Journal:  Arthritis Res Ther       Date:  2017-11-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.